Regulation of cyclic nucleotide hydrolysis by cGMP.
- Published in:
- BMC Pharmacology, 2005, v. 5, p. S9, doi. 10.1186/1471-2210-5-S1-S9
- Publication type:
- Article
Works matching IS 14712210 AND DT 2005 AND VI 5
Results: 120
1
2
A cGMP-dependent protein kinase plays a pivotal role in the control of behavioral quiescence in C. elegans.
- Published in:
- BMC Pharmacology, 2005, v. 5, p. S8, doi. 10.1186/1471-2210-5-S1-S8
- Publication type:
- Article
3
Atypical soluble guanylyl cyclases in Drosophila as neutral oxygen sensors and their involvement in gestation.
- Published in:
- BMC Pharmacology, 2005, v. 5, p. S7, doi. 10.1186/1471-2210-5-S1-S7
- Publication type:
- Article
4
Role of cGMP dependent protein kinases in the circadian system.
- Published in:
- BMC Pharmacology, 2005, v. 5, p. S6, doi. 10.1186/1471-2210-5-S1-S6
- Publication type:
- Article
5
Selective inhibitors of cGMP phosphodiesterases as procognitive agents.
- Published in:
- BMC Pharmacology, 2005, v. 5, p. S5, doi. 10.1186/1471-2210-5-S1-S5
- Publication type:
- Article
6
Role of cGMP in learning: alterations in pathological situations and therapeutic implications.
- Published in:
- BMC Pharmacology, 2005, v. 5, p. S4, doi. 10.1186/1471-2210-5-S1-S4
- Publication type:
- Article
7
Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia.
- Published in:
- BMC Pharmacology, 2005, v. 5, p. P66, doi. 10.1186/1471-2210-5-S1-P66
- Publication type:
- Article
8
Analysis of BK<sub>Ca</sub> channel deficient mice.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
9
Role of nitric oxide and cyclic GMP in proliferation and differentiation of murine and human embryonic stem cells.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
10
Genetic dissection of signaling via cGMP-dependent protein kinases.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
11
Lessons from soluble guanylate cyclase alpha1 knockouts.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
12
Urodilatin, the renal natriuretic peptide: preclinical and clinical review.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
13
Effects of stimulating the cGMP pathway on spontaneous activity in pacemaker cells isolated from the rabbit urethra.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
14
Role of cGMP in natriuresis and pressure-natriuresis.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
15
Role of soluble guanylate cyclase in progressive renal fibrosis.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
16
Endothelium-mediated actions of the ANP/cGMP system.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
17
NO-cGMP signaling in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
18
Resonance raman investigation of effects of YC-1 and GTP on structure of CO-bound heme of soluble guanylate cyclase.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
19
sGC activation in pulmonary hypertension.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
20
Soluble guanylate cyclase stimulator attenuates acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
21
Differential effects of nitric oxide donors and phosphodiesterase 5 inhibitors on vascular function in humans.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
22
Role of PDE5a in cardiac stress response.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
23
Nitric oxide-independent regulation of the vascular injury response.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
24
Functional role of cGMP-dependent VASP phosphorylation in vascular cells.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
25
Creation and characterization of mice with selective mutation of the cyclic GMP-dependent protein kinase I interaction domain.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
26
cGMP enhancing strategies for acute and chronic heart failure.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
27
Aspirin activates HO-1 expression in endothelial cells -- role of NO/cGMP.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
28
The nitroxyl anion (NO): a novel regulator of sGC and vascular tone.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
29
New vistas on NO-cGMP signalling.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
30
Role of activators of ferric sGC in cardiovascular disease.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
31
Beyond NO and heme: biochemical and pharmacological opportunities.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
32
Bacterial GAF domains.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
33
Regulation of PKG expression in vascular smooth muscle cells.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
34
Exploring vasomotor mechanisms using PKG specific inhibitors.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
35
Regulation of smooth muscle specific gene expression by PKG and mechanisms regulating PKG expression in smooth muscle cells.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
36
Function of IRAG for cGMP kinase signalling in smooth muscle and platelets.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
37
Does soluble guanylyl cyclase need a chaperone?
- Published in:
- 2005
- By:
- Publication type:
- Abstract
38
Reactive oxygen species induce tyrosine phosphorylation of and Src kinase recruitment to NO-sensitive guanylyl cyclase.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
39
NO/cGMP signalling.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
40
Molecular steps in soluble guanylate cyclase activation.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
41
PDE2 and PDE5 exert specific and distinct roles in regulating cGMP signals elicited by particulate or soluble guanylyl cyclases in rat cardiac myocytes.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
42
Kinetics of NO-induced cyclic GMP responses in vascular smooth muscle.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
43
Myocyte-specific overexpression of NOS3 prevents endotoxin-induced myocardial dysfunction in mice.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
44
Interaction between hsp90 and soluble guanylyl cyclase: physiological significance and mapping of the domains mediating binding.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
45
Characterization of the novel PDE9 inhibitor BAY 73-6691 using a cGMP reporter cell line.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
46
Protein kinase A mediates 8-Br-cGMP-induced Ca<sup>2+</sup>-desensitization in murine aorta.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
47
Regulation of vascular smooth muscle growth by cyclic nucleotides and cGMP-dependent protein kinase.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
48
Inhaled NO and the guanylate cyclase stimulator Bay 41-2272 oleic acid induced acute lung injury in rabbits.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
49
IRAG is involved in cGMP/cGK-mediated relaxation of contractions induced by calcium entry.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
50
3-(3-[1,2,4]triazolo)-oxatriazolium-5-olate causes vasodilatation by NO-independent activation of soluble guanylate cyclase.
- Published in:
- 2005
- By:
- Publication type:
- Abstract